AQR Capital Management
MIRM icon

AQR Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

AQR Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35M Sell
28,647
-3,144
-10% -$316K ﹤0.01% 2271
2026
Q1 		$2.94M Sell
31,791
-694
-2% -$65.3K ﹤0.01% 2096
2025
Q4 		$2.57M Buy
32,485
+1,090
+3% +$78.2K ﹤0.01% 1977
2025
Q3 		$2.3M Sell
31,395
-16,121
-34% -$1.02M ﹤0.01% 1896
2025
Q2 		$2.42M Sell
47,516
-1,560
-3% -$69.5K ﹤0.01% 1670
2025
Q1 		$2.21M Buy
49,076
+37,028
+307% +$1.75M ﹤0.01% 1554
2024
Q4 		$498K Sell
12,048
-497
-4% -$20.7K ﹤0.01% 2252
2024
Q3 		$489K Buy
12,545
+4,251
+51% +$170K ﹤0.01% 2179
2024
Q2 		$284K Sell
8,294
-23,721
-74% -$622K ﹤0.01% 2291
2024
Q1 		$804K Buy
32,015
+19,139
+149% +$526K ﹤0.01% 1784
2023
Q4 		$380K Sell
12,876
-2,667
-17% -$80.7K ﹤0.01% 1990
2023
Q3 		$491K Buy
15,543
+3,317
+27% +$90.8K ﹤0.01% 1846
2023
Q2 		$316K Sell
12,226
-2,320
-16% -$61.7K ﹤0.01% 1923
2023
Q1 		$349K Buy
14,546
+247
+2% +$5.63K ﹤0.01% 1898
2022
Q4 		$279K Buy
14,299
+3,579
+33% +$70.7K ﹤0.01% 1996
2022
Q3 		$225K Buy
+10,720
New +$258K ﹤0.01% 2019

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management's MIRM Position: Q2 2026 in Review

AQR Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 9.9% in Q2 2026, selling an estimated $316K and leaving 28,647 shares worth $3.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2271.

AQR Capital Management first reported a position in MIRM in Q3 2022 and has held it in 16 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • AQR Capital Management held 28,647 shares of Mirum Pharmaceuticals worth $3.35M as of Q2 2026.
  • AQR Capital Management sold 3,144 Mirum Pharmaceuticals shares in Q2 2026, an estimated $316K.
  • Mirum Pharmaceuticals made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2271 holding.
  • AQR Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.